Vaccines Europe paper on antimicrobial resistance (AMR)

2016 11 16 Written by Vaccines Europe

The frequency of antimicrobial resistance (AMR) is increasing in Europe and constitutes a serious danger to public health. Evidence has shown that existing vaccines have a positive impact in reducing AMR. In addition, new vaccines could play a critical role in preventing multi-drug resistant infections, such as from S. aureus, C. difficile and E. coli.

Access and download our paper here.

In 2017, MSD has collaborated with leading public health experts to develop a video exploring the role of vaccines in helping combat antimicrobial resistance. Access it here.

Post a new comment